Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 10/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28791865 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787151 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL29266178 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL30787432 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL15155875 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL24761603 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL1773385 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL226634 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL7865459 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 | |
| SCHEMBL27808460 | 1.00 | FDPS (0.50) | FDPSGGPS1TSHRTHRBSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4554379-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | Apeo - Agronomical Plant Extracts & Essential Oils (BE) | 2025-05-21 | — | — | EP | disclosed |
| WO-2024013148-A1 | USE OF AN ALKANEDIOL AS HERBICIDE | APEO – AGRONOMICAL PLANT EXTRACTS & ESSENTIAL OILS (BE) | 2024-01-18 | — | — | WO | disclosed |
| US-20100298256-A1 | ANTIVIRAL COMPOUNDS | EPIPHANY BIOSCIENCES, INC. | 2010-11-25 | — | — | US | disclosed |
| EP-2234623-A1 | ANTIVIRAL COMPOUNDS | Epiphany Biosciences (US) | 2010-10-06 | — | — | EP | disclosed |
| WO-2009085267-A1 | ANTIVIRAL COMPOUNDS | EPIPHANY BIOSCIENCES (US) | 2009-07-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298256-A1 | ANTIVIRAL COMPOUNDS | MTAP, PNP, TYMP | FDPS 187/4885GGPS1 49/4885TSHR 4522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.